Financials
- Market Capitalization 412.74 M
- Employee 35
- Founded 1996
- CEO N/A
- Website www.fennecpharma.com
- Headquarter British Columbia, Canada
- FIGI BBG000DTH814
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-22.65
Rapporto prezzo/fatturato
4.93
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3050 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.23 USD | +1.44% | +4.44% | +7.63% | +42.42% | 419.39 M USD | ||
| 3052 | GALT Galectin Therapeutics Inc. - Common Stock | 4.14 USD | -0.24% | +14.36% | +20.70% | -1.43% | 417.52 M USD | ||
| 3069 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.99 USD | -0.40% | -2.54% | +13.67% | +3.74% | 409.41 M USD | ||
| 3074 | IPSC Century Therapeutics, Inc. - Common Stock | 2.23 USD | +4.21% | +8.78% | +9.31% | +337.25% | 403.80 M USD |